In 2017, the export of pharmaceutical preparations was US$3.456 billion, an increase of 8.32% over the same period of the previous year. Specifically, it has three characteristics. First, the growth point in the international market is changing. For the European Union, North America regulates the market with strong growth, including exports to the EU of US$670 million, a substantial increase of 53.51%. Exports to Africa increased by 11.2%, while the Asian market remained flat, with exports falling by 7.83%. Second, R&D and innovative pharmaceutical companies' exports gradually became the main force driving exports of pharmaceutical preparations. Huahai Pharmaceutical, Hengrui Pharmaceutical, and Guilin South Pharmaceutical and other pharmaceutical companies were While exports continued to grow at a rapid rate, the number of access to ANDA in the United States continued to grow, opening up space for subsequent growth.
The list of top 20 Western medicines export enterprises in 2017 (local companies) is as follows:
Click on the image below to register for the exhibition!
